BG
CLMT icon

Bahl & Gaynor’s Calumet Specialty Products CLMT Stock Holding History

Bahl & Gaynor’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-6,500
Closed -$207K – 427
2014
Q2 		$207K Buy
+6,500
New +$193K ﹤0.01% 389
2013
Q4 		– Sell
-7,350
Closed -$201K – 383
2013
Q3 		$201K Hold
7,350
– – ﹤0.01% 356
2013
Q2 		$267K Buy
+7,350
New +$264K 0.01% 321

Other funds holding CLMT

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EAM
Edge Asset Management Seattle, Washington $13.2B AUM 19.52% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
IMS
Index Management Solutions Philadelphia, Pennsylvania $101M AUM 12.09% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CA
Corrado Advisors Ramsey, New Jersey $192M AUM 20.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Bahl & Gaynor's CLMT Position: Q3 2014 in Review

Bahl & Gaynor sold out of Calumet Specialty Products (CLMT) in Q3 2014, closing a stake of 6,500 shares — an estimated $207K sold.

Bahl & Gaynor first reported a position in CLMT in Q2 2013 and held it in 3 quarters. The position peaked at $267K in Q2 2013. 115 funds tracked by Wall St. Rank hold CLMT as of Q3 2014.

  • Bahl & Gaynor reported no remaining Calumet Specialty Products position as of Q3 2014 after selling out during the quarter.
  • Bahl & Gaynor sold 6,500 Calumet Specialty Products shares in Q3 2014, an estimated $207K.
  • Bahl & Gaynor first reported a position in Calumet Specialty Products in Q2 2013 and held it in 3 quarters.
  • Bahl & Gaynor's Calumet Specialty Products position peaked at $267K in Q2 2013.
  • 115 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2014.

Based on Bahl & Gaynor's 13F filing for Q3 2014, filed 12 Nov 2014.